Comment to "Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer"

Radiother Oncol. 2023 Dec:189:109919. doi: 10.1016/j.radonc.2023.109919. Epub 2023 Sep 28.

Authors

Yu-Tzu Chien¹, Yung-Shuo Kao²

Affiliations

¹ Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.
² Department of Radiation Oncology, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan; Department of Research and Development, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan. Electronic address: codingforlifetime@gmail.com.

PMID: 37776904
DOI: 10.1016/j.radonc.2023.109919

No abstract available

Publication types

Letter

MeSH terms

Humans
Male
Prostatic Neoplasms* / radiotherapy
Prostatic Neoplasms* / surgery
Quality of Life
Radiometry
Radiosurgery* / adverse effects